Cardiovascular Meds May Be Beneficial in Alzheimer’s Disease, According to MedPredict Report
SCOTTSDALE, Ariz., May 29, 2008 /PRNewswire/ — MedPredict has
published a new report designed to provide critical strategic
insight for pharma and biotech companies with a stake in the market
for diagnostics and treatments in this disease area. The…
Settlement: McKesson Corp.
$13.25 million settlement in lifestyle drug abuse lawsuit.
Possible Case: Mommy’s Bliss
Nipple Cream Potentially Harmful
Merck Wins Appeal of First Vioxx Case to go to Trial
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–May 29, 2008 - Merck
& Co., Inc. said today that it is gratified that a Texas
appeals court overturned the August 2005 verdict of a state court
jury in Brazoria County and rendered a judgment in favor…
Texas, N.J. Courts Toss Vioxx Verdicts
Appeals courts in New Jersey and Texas have scrapped verdicts against drugmaker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx.
A Texas court scrapped a $26 million verdict against the drugmaker stemming from the first trial. The court found no evidence that Robert Ernst suffered a fatal heart problem from a blood clot triggered by Vioxx. He had been taking the now-withdrawn drug for eight months before being stricken in May 2001.
A New Jersey appeals court separately voided $9 million of the nearly $14 million awarded to John McDarby in 2006 by a jury in Atlantic City. The panel found that New Jersey’s Product Liability Act was pre-empted by the federal Food Drug and Cosmetic Act.
Merck Wins Appeal of First Vioxx Case to Go to Trial
The following statement was issued today by Merck, from Bruce
Kuhlik, executive vice president and general counsel:
WHITEHOUSE STATION, N.J., May 29, 2008 -
“We are gratified that the Texas appeals court correctly found that
VIOXX did…
Bristol-Myers Squibb to Acquire Kosan Biosciences
Bristol-Myers Squibb Advances Company Strategy with Latest
Acquisition
PRINCETON, N.J. and HAYWARD, Calif., May 29, 2008 (BUSINESS WIRE)
– Bristol-Myers Squibb Company (NYSE: BMY) and Kosan Biosciences
Inc. (NASDAQ: KOSN) announced today that the…
Mommy’s Bliss Nipple Cream
Product contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in infants.
Sun Pharma responds to Taro’s purported termination of merger agreement
MUMBAI, India: May 29, 2008 - Sun Pharmaceutical Industries
Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:
524715) today sent a letter to Barrie Levitt, M.D., Chairman of
Taro Pharmaceutical Industries Ltd. (Taro, Pink Sheets:…
Favrille Announces Workforce Reduction
SAN DIEGO, May 29, 2008 /PRNewswire-FirstCall/ — Favrille, Inc.
today announced that it has provided a notice to 132 of its 144
employees, including six of its eight executive officers, that
their employment with the Company will end on June 6,…